IESE (España)
-
BioRecilGent (B)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-381-EDecision AnalysisThe case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.Starting at €5.74
-
BioRecilGent (A)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-380Decision AnalysisEl caso presenta el desarrollo de un fármaco que todavía no está aprobado. Muestra las distintas opciones que tiene la empresa que lo desarrolla, según las diferentes fases para su aprobación.Starting at €8.20
-
Driving Innovation Through Intrapreneurship at Chiesi (Portuguese Version, Brazil)
Castelltort, Albert; Davila, AntonioCase E-193-PBEntrepreneurship, Innovation and ChangeChiesi Farmacuetici developed a new program to create a more entrepreneurial culture in its Spanish division. The program was based on Lean Startup principles with employees moving from selecting an idea to developing a business. However, at the end of the program, unexpected challenges arose.Starting at €8.20
-
Impulsar la innovación a través de la iniciativa emprendedora en el seno de Chiesi
Castelltort, Albert; Davila, AntonioCase E-193Entrepreneurship, Innovation and ChangeChiesi Farmaceutici desarrolló un nuevo programa para crear una cultura más emprendedora en su división de España. El programa se basaba en los principios de Lean Startup, según los que los empleados debían pasar de una idea seleccionada a desarrollar un negocio. Sin embargo, al final de programa surgieron retos no previstos.Starting at €8.20
-
Driving Innovation Through Intrapreneurship at Chiesi
Castelltort, Albert; Davila, AntonioCase E-193-EEntrepreneurship, Innovation and ChangeChiesi Farmacuetici developed a new program to create a more entrepreneurial culture in its Spanish division. The program was based on Lean Startup principles with employees moving from selecting an idea to developing a business. However, at the end of the program, unexpected challenges arose.Starting at €8.20
-
BioRecilGent (B)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-381Decision AnalysisEl caso presenta el desarrollo de un fármaco que todavía no está aprobado. Muestra las distintas opciones que tiene la empresa que lo desarrolla, según las diferentes fases para su aprobación.Starting at €5.74
-
BioRecilGent (A)
Miguel A. Ariño; Rodríguez Mariscal, ManuelCase AD-380-EDecision AnalysisThe case focuses on the development of a yet-to-be-approved drug. It presents the various options open to the company developing the drug in the context of the phases that the medicine must go through to be approved.Starting at €8.20